Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (131-140 of 459) with videos related to

Pageof 46
Sort By:
Carcinogenesis|February 12, 2011
Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cellsSara Caprodossi, Consuelo Amantini, Massimo Nabissi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 15, 2016
Urothelial Cancer: Inflammatory Mediators and Implications for ImmunotherapyGiuseppe Schepisi, Matteo Santoni, Francesco Massari, et al.
International Journal of Molecular Sciences|July 27, 2022
Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma PatientsGiorgio Santoni, Federica Maggi, Consuelo Amantini, et al.
Cancers|February 10, 2019
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid BiopsyAlessia Cimadamore, Silvia Gasparrini, Francesco Massari, et al.
Diagnostic Pathology|October 19, 2014
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?Rodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, et al.
British Journal of Clinical Pharmacology|August 29, 2013
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancyRoberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, et al.
European Urology|September 4, 2015
Re: epithelial-to-mesenchymal transition in renal neoplasmsRodolfo Montironi, Matteo Santoni, Marina Scarpelli, et al.
Cancers|July 24, 2021
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker EvaluationAlessia Cimadamore, Roberta Mazzucchelli, Antonio Lopez-Beltran, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
International Journal of Molecular Sciences|December 24, 2021
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKTVeronica Mollica, Andrea Marchetti, Matteo Rosellini, et al.
Pageof 46

Showing results (131-140 of 459) with videos related to

Sort By:
Pageof 46
Carcinogenesis|February 12, 2011
Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cellsSara Caprodossi, Consuelo Amantini, Massimo Nabissi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 15, 2016
Urothelial Cancer: Inflammatory Mediators and Implications for ImmunotherapyGiuseppe Schepisi, Matteo Santoni, Francesco Massari, et al.
International Journal of Molecular Sciences|July 27, 2022
Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma PatientsGiorgio Santoni, Federica Maggi, Consuelo Amantini, et al.
Cancers|February 10, 2019
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid BiopsyAlessia Cimadamore, Silvia Gasparrini, Francesco Massari, et al.
Diagnostic Pathology|October 19, 2014
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?Rodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, et al.
British Journal of Clinical Pharmacology|August 29, 2013
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancyRoberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, et al.
European Urology|September 4, 2015
Re: epithelial-to-mesenchymal transition in renal neoplasmsRodolfo Montironi, Matteo Santoni, Marina Scarpelli, et al.
Cancers|July 24, 2021
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker EvaluationAlessia Cimadamore, Roberta Mazzucchelli, Antonio Lopez-Beltran, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
International Journal of Molecular Sciences|December 24, 2021
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKTVeronica Mollica, Andrea Marchetti, Matteo Rosellini, et al.
Pageof 46